Results 231 to 240 of about 227,143 (302)
Bene Mori: The Right of the Patient to Die with Dignity [PDF]
Cavanagh, John R.
core +1 more source
Public Deliberation for Ethically Complex Policies: The Case of Medical Assistance in Dying in Canada. [PDF]
Dhamanaskar R, Abelson J.
europepmc +1 more source
Objective A leading cause of death among patients with scleroderma (SSc), interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M. Padilla +13 more
wiley +1 more source
Exploring the interplay of clinical, ethical and societal dynamics: two decades of Medical Assistance in Dying (MAID) on psychiatric grounds in the Netherlands and Belgium. [PDF]
Verhofstadt M +8 more
europepmc +1 more source
Objective We assessed whether circulating adipokines are associated with incident fractures in patients with rheumatoid arthritis (RA). Methods Three adipokines (adiponectin, leptin, and fibroblast growth factor [FGF]‐21) were measured using banked enrollment serum from participants in a longitudinal RA cohort.
Joshua F. Baker +9 more
wiley +1 more source
Objective We conducted formative research aimed at identifying solutions that address inequitable health outcomes in lupus due to adverse social determinants of health (SDoH). Methods We conducted a search for keywords, which provided insights into potential solutions and initiatives underway. An advisory panel of lupus experts iteratively reviewed the
Joy Buie +11 more
wiley +1 more source
Human Death as Neocortical Death: The Ethical Context [PDF]
Weber, Leonard J.
core +1 more source
'My Advocacy is Not About Me, My Advocacy is About Canadians': A Qualitative Study of how Caregivers and Patients Influence Regulation of Medical Assistance in Dying in Canada. [PDF]
Jeanneret R +4 more
europepmc +1 more source
Objective This study aimed to identify in patients with systemic lupus erythematosus (SLE) with clinically active disease the attainment of frequency and determinants of Lupus Low Disease Activity State (LLDAS) and Definition of Remission in SLE (DORIS) and the frequency and determinants of flare and damage accrual after target attainment.
Yanjie Hao +39 more
wiley +1 more source
Organ donation after medical assistance in dying: a descriptive study from 2018 to 2022 in Quebec. [PDF]
Weiss MJ +5 more
europepmc +1 more source

